Business Context and Reporting Period
K&F Growth Acquisition Corp. II, a Cayman Islands-based emerging growth company, filed this Form 8-K on February 10, 2025, reporting events occurring between February 4 and February 6, 2025. The filing documents the consummation of the Company's initial public offering (IPO) and the entry into several material definitive agreements necessary to commence operations as a Special Purpose Acquisition Company (SPAC).
Key Financial Metrics
- IPO Gross Proceeds: $287,500,000 from the sale of 28,750,000 Units at $10.00 per Unit (including full exercise of the over-allotment option).
- Private Placement Proceeds: $9,227,270 from the sale of 922,727 Private Placement Units to the Sponsor and BTIG, LLC at $10.00 per unit.
- Total Capital Raised: $296,727,270.
- Trust Account Funding: $288,937,500 deposited into a U.S.-based trust account. This amount includes $10,062,500 in deferred underwriting commissions.
- Working Capital: $1,289,770 allocated to the Company's working capital account from private placement proceeds to cover offering expenses.
- Debt and Liquidity: The filing does not disclose existing debt obligations. Liquidity is primarily derived from the IPO proceeds held in trust and the working capital account.
Material Changes and Corporate Actions
- Capital Structure: The Company transitioned from a pre-IPO entity to a public company with Class A ordinary shares (trading symbol: KFII), Units (KFIIU), and Rights (KFIIR) listed on The Nasdaq Stock Market LLC.
- Board Composition: On February 5, 2025, James Murren, Joyce Arpin, and Geoff Freeman were appointed to the Board of Directors, joining Edward King and Daniel Fetters. Ms. Arpin was named Chair of the Audit Committee, and Mr. Freeman was named Chair of the Compensation Committee.
- Corporate Governance: The Company filed its Amended and Restated Memorandum and Articles of Association, establishing a 21-month deadline from the IPO closing to consummate an initial business combination.
- Agreements Executed: Entered into underwriting, share rights, trust, registration rights, private placement, and indemnity agreements.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The Company must complete an initial business combination within 21 months of the IPO closing (approximately November 2026) or face liquidation.
- Redemption Rights: Public shareholders may redeem their shares for a pro-rata portion of the trust account if the Company fails to complete a business combination within the specified timeframe or in connection with certain amendments to its charter.
- Trust Account Restrictions: Funds in the trust account ($288,937,500) are generally restricted until the completion of a business combination, liquidation, or specific shareholder votes. Interest earned may be released to pay taxes, and up to $100,000 may be used for winding-up expenses.
- Deferred Commissions: $10,062,500 of underwriting commissions are deferred and will be payable only upon the consummation of an initial business combination.
Investor Verification Checklist
- Verify the exact closing date of the IPO (February 6, 2025) against the 21-month liquidation deadline.
- Confirm the total amount held in the trust account ($288,937,500) and the specific terms regarding the release of interest for tax purposes.
- Review the Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for specific redemption thresholds and amendment procedures.
- Assess the Sponsor's commitment via the Private Placement Units (922,727 units) and the alignment of interests with public shareholders.
- Monitor the status of the deferred underwriting commissions ($10,062,500) contingent on a successful business combination.